Walleye Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Walleye Capital’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-14,400	Closed	-$566K	–	5589
2023 Q2	$566K	Buy	14,400 +7,600	+112%	+$268K	﹤0.01%	2344
2023 Q1	$165K	Buy	+6,800	New	+$149K	﹤0.01%	2606
2022 Q4	–	Sell	-10,000	Closed	-$179K	–	3805
2022 Q3	$179K	Buy	+10,000	New	+$131K	﹤0.01%	2184

Walleye Capital's ISEE Position: Q3 2023 in Review

Walleye Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 65,805 shares — an estimated $2.59M sold.

Walleye Capital first reported a position in ISEE in Q1 2020 and held it in 9 quarters. The position peaked at $11.5M in Q3 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Walleye Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Walleye Capital sold 65,805 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $2.59M.
Walleye Capital first reported a position in IVERIC bio, Inc. Common Stock in Q1 2020 and held it in 9 quarters.
Walleye Capital's IVERIC bio, Inc. Common Stock position peaked at $11.5M in Q3 2022.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Walleye Capital's 13F filing for Q3 2023, filed 14 Nov 2023.